Acute hepatitis B with delta-agent
ICD-10 B16.0 is a billable code used to indicate a diagnosis of acute hepatitis b with delta-agent.
Acute hepatitis B with delta-agent is a viral infection of the liver caused by the hepatitis B virus (HBV) in conjunction with the hepatitis D virus (HDV), also known as the delta agent. This condition is characterized by the presence of both viruses, which can lead to more severe liver disease than infection with HBV alone. Transmission occurs primarily through contact with infectious body fluids, such as blood, semen, or vaginal secretions. High-risk populations include intravenous drug users, men who have sex with men, and individuals with multiple sexual partners. Acute hepatitis B with delta-agent can present with symptoms such as jaundice, fatigue, abdominal pain, and elevated liver enzymes. Chronic management may involve antiviral therapy, monitoring liver function, and regular screening for liver complications, including cirrhosis and hepatocellular carcinoma. The presence of the delta agent complicates the clinical course and management of hepatitis B, often leading to a more aggressive disease progression and a higher risk of liver-related complications.
Detailed history of liver disease, laboratory results, and treatment plans.
Patients presenting with jaundice, elevated liver enzymes, or complications from hepatitis.
Ensure documentation reflects the severity of liver disease and any co-morbid conditions.
Comprehensive patient history, risk factors for transmission, and response to antiviral therapy.
Patients with acute hepatitis symptoms and a history of high-risk behaviors.
Document any co-infections and the patient's vaccination status against hepatitis A and B.
Used to confirm diagnosis of hepatitis B infection.
Document the reason for testing and results.
Gastroenterology may require additional tests for liver function.
Hepatitis B is a viral infection that can occur alone, while hepatitis D requires the presence of hepatitis B to replicate. Co-infection with both can lead to more severe liver disease.
